Left atrial appendage: structure, function, and role in thromboembolism

N M Al-Saady1, O A Obel, A J Camm

  • 1Cardiological Sciences, St George's Hospital Medical School, Cranmer Terrace, London SW17 0RE, UK. nalsaady@sghms.ac.uk

Insights

The left atrial appendage (LAA) functions as a decompression chamber due to its unique properties. However, interventions like LAA obliteration may reduce thromboembolism risk but can impact atrial compliance and ANF secretion.

Area of Science:

  • Cardiology
  • Embryology
  • Physiology

Background:

  • The left atrial appendage (LAA) originates from the primary atrium during embryonic development.
  • It possesses distinct developmental, ultrastructural, and physiological features compared to the main left atrium.
  • Its anatomical proximity to the left ventricle influences its function.

Purpose of the Study:

  • To elucidate the distinct physiological roles and anatomical relations of the LAA.
  • To understand the factors contributing to thrombus formation in the LAA.
  • To evaluate the consequences of LAA interventions on cardiac function.

Main Methods:

  • Review of developmental and anatomical data.
  • Analysis of physiological properties including distensibility and neuroanatomy.
  • Examination of factors contributing to thrombus formation.
  • Assessment of potential sequelae from LAA obliteration or amputation.

Main Results:

  • The LAA acts as a decompression chamber due to its position, distensibility, atrial natriuretic factor (ANF) content, and neuronal structure.
  • Thrombus formation in the LAA is common in conditions like atrial fibrillation and mitral valve disease, likely due to blood stasis.
  • LAA obliteration may reduce thromboembolic risk but can lead to reduced atrial compliance and ANF secretion.

Conclusions:

  • The LAA has specialized physiological functions, including acting as a decompression chamber and secreting ANF.
  • Blood stasis within the LAA's unique shape and trabeculations contributes to thrombus formation.
  • Interventions targeting the LAA require careful consideration of potential adverse physiological effects.

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Chambers of the Heart01:16

Chambers of the Heart

The human heart is a complex organ made up of four chambers: the right and left atria and the right and left ventricles. These internal chambers are separated by partitions known as the interatrial and interventricular septa. The exterior of the heart features a groove known as the coronary sulcus that demarcates the atria from the ventricles, while the anterior and posterior interventricular sulci distinguish between the two ventricles.
Deoxygenated blood from the body is received in the right...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...